
USFDA APPLICATION NUMBER - 20021 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 240MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| Pseudoephedrine Hydrochloride(UNII: 6V9V2RYJ8N) (pseudoephedrine - UNII:7CUC9DDI9F) | Pseudoephedrine Hydrochloride | 240mg |
Inactive Ingredients
| Ingredient Name | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
|---|---|
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| HYDROXYPROPYL CELLULOSE (70000 WAMW)(66O7AQV0RT) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| magnesium stearate(70097M6I30) | |
| microcrystalline cellulose(OP1R32D61U) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| polysorbate 80(6OZP39ZG8H) | |
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |
| propylene glycol(6DC9Q167V3) | |
| shellac(46N107B71O) | |
| sodium chloride(451W47IQ8X) | |
| titanium dioxide(15FIX9V2JP) |